Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation.
Yury A SurovoyMaksim A BurkinInna A GalvidisPavel O BochkovArmen V OganesyanSergei V TsarenkoPublished in: The Journal of antimicrobial chemotherapy (2022)
Currently recommended polymyxin B dosage regimens are sufficient for patients receiving ECMO and no dosage increase is required. In our study, polymyxin B exposure was higher in ECMO patients compared with the control group.